Skip to main content
. 2012 Nov;19(11):1806–1809. doi: 10.1128/CVI.00383-12

Table 1.

Demographic and baseline historical information

Characteristic Value
Age (yr) [mean ± SD (range)] 47.7 ± 11.9 (32–73)
Male [n (%)] 4 (36)
Caucasian [n (%)] 11 (100)
Preexisting conditions [n (%)] 6 (54)
    Osteoarthritis 4 (36)
    Rheumatoid arthritis 1 (9)
    Spondyloarthropathy 1 (9)
Distribution of arthritis [n (%)]
    Monoarticular 6 (54)
    Oligoarticular 5 (46)
Joint aspirated [n (%)]
    Knee 9 (82)
    Wrist 1 (9)
    Elbow 1 (9)
Course of arthritis/joint effusion [n (%)]
    Intermittent 11 (100)
    Persistent 0 (0)
Time since onset of arthritis prior to consultation (days) [mean (range)] 1051 (122–2555)
History of erythema migrans rash [n (%)] 1 (9)
History of tick bite [n (%)] 1 (9)
Concurrent symptoms at time of consultation visit [n (%)]
    Arthralgia 11 (100)
    Subjective cognitive dysfunction 6 (54)
    Fatigue 4 (36)
    Myalgia 2 (18)
Prescribed antibiotic coursesa
    Total no. of days of antibiotic therapy for seronegative patients [mean (range)] 72 (10–165)
    Seronegative patients treated with oral antibioticsb [n (%)] 10 (100)
    Duration (days) [mean (range)] 53 (10–108)
    Patients treated with parenteral antibioticsc [n (%)] 5 (45)
    Duration (days) [mean (range)] 38 (2–70)
    Patients simultaneously receiving intravenous and oral antibiotics [n (%)] 5 (45)
a

Of the 10 seronegative patients.

b

Doxycycline, amoxicillin, clarithromycin, or azithromycin.

c

Ceftriaxone.